Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a website keep your mind sharp? new study tests remote brain training for seniors

NCT ID NCT07668440

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 29, 2026 · Updated 3 times

Summary

This study tests a 12-week remote program for adults aged 60-75 at risk of cognitive decline. The program includes aerobic exercise, cognitive training, and education on healthy aging, all delivered through a website. Researchers will measure whether the program improves memory, thinking skills, and daily function, and assess how easy it is for older adults to use. The goal is to find a practical way to prevent dementia in a growing older population.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multi-domain intervention: physical activity, cognitive training, and educational program delivered via a website
What this could lead to
If successful, this could provide an accessible, low-cost way to help older adults maintain cognitive health and potentially delay or prevent dementia.
What could go wrong
This is a small pilot study with no control group, so results may not be conclusive. Older adults may face barriers using digital tools, which could affect participation and outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 71 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * With and without cognitive complaints (i.e., they have responded 'yes' to the question: 'Do you feel that your memory or learning abilities have worsened recently?"). * They demonstrate independence in activities of daily living and instrumental activities of daily living. • With one or more vascular risk factors (for example, type 2 diabetes or hypertension). * With a score on the overall cognitive function test of≥ 24 on the Mini-Mental State Examination. * With a score between 0-4 on the Blessed Dementia Scale. * With a mobile phone or computer. * Have a companion, such as a child, spouse, or friend, who can support you during the assessment in case of an emergency. * Voluntary acceptance to participate in the study through a signed informed consent form prior to your participation. Exclusion Criteria: * Depression (score \> 15 according to the Epidemiological Studies Center Depression Scale - Revised \[CESD-R\]). * With a clinical diagnosis of any significant neurological or psychiatric disorder (for example, Parkinson's disease, schizophrenia). * With any heart disease. * Presence of a recent cancer diagnosis. * History of recent severe cardiovascular event (for example, myocardial infarction, stroke). * Significant orthopedic conditions (for example, severe osteoarthritis). * Uncontrolled blood pressure (very high \> 180/100 mmHg or very low \< 100/60 mmHg). * Severe visual or hearing impairment. * Type 2 Diabetes Mellitus requires insulin to control hyperglycemia.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coginitive dysfunction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cognitive disorder Cognitive Dysfunction Motor Activity dementia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Avenida Cuahutémoc 330

    Mexico City, Mexico City, 06401, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.